BD has become the subject of a lawsuit from Tela Bio, with the rival maker of surgical mesh implants saying the major medtech wielded its sector dominance to push competing products out o | The rival ...
Zacks Investment Research on MSN
BD and Penn Institute ink collaboration to advance immunotherapy
Becton, Dickinson and Company BDX, popularly known as BD, recently announced a collaboration with the Institute for ...
Reuters reported the suit, which was filed in the court for the Eastern District of Pennsylvania on Dec. 19. According to the ...
IGIB, has launched India's first Centre of Excellence for Single-Cell Multiomics to enhance research in immunity, cancer, and ...
Becton, Dickinson and Co. is increasing its U.S. manufacturing capacity for essential medical devices, including syringes, needles and IV catheters. As part of a $10 million investment in 2024, new ...
Zacks Investment Research on MSN
Are options traders betting on a big move in BD stock?
Investors in Becton, Dickinson and Company BDX need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 16, 2026 $225.00 Put had some of the ...
With all the buzzwords surrounding artificial intelligence, from smiling promotions to angry chagrins—promises that it will ...
BD (Becton, Dickinson and Company), a leading global medical technology company, today will commemorate 55 years of manufacturing excellence at its Sumter, South Carolina facility, which throughout ...
FRANKLIN LAKES, N.J. & SAN DIEGO--(BUSINESS WIRE)--BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biosero, a developer of laboratory automation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback